miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.

Cataldo A, Cheung DG, Balsari A, Tagliabue E, Coppola V, Iorio MV, Palmieri D, Croce CM
Oncotarget. 2016 Jan 5;7(1):786-97. doi: 10.18632/oncotarget.6381. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.